| S.No. | Product name | Therapeutic Use |
|---|---|---|
| 1 | Apixaban tablets 2.5 mg | Anti-coagulant (heart disease) |
| 2 | Apixaban tablets 5 mg | Anti-coagulant (heart disease) |
| 3 | Atenolol Tablets IP 50 mg | Blood Pressure |
| 4 | Atenolol Tablets IP 100 mg | Blood Pressure |
| 5 | Atorvastatin Calcium Tablets 10 mg | Cholesterol |
| 6 | Atorvastatin Calcium Tablets 20 mg | Blood Pressure |
| 7 | Atorvastatin Calcium Tablets 40 mg | Cholesterol |
| 8 | Atorvastatin Calcium Tablets 80 mg | Cholesterol |
| 9 | Divalproex Sodium Extended-Release Tablets IP 500 mg | Epilepsy |
| 10 | Empagliflozin tablets 10 mg | Diabetes |
| 11 | Empagliflozin tablets 25 mg | Diabetes |
| 12 | Esomeprazole Delayed Release Tablets IP 20 mg | Acidity |
| 13 | Esomeprazole Delayed Release Tablets IP 40 mg | Acidity |
| 14 | Hydroxychloroquine sulphate tablets 300 mg | Rheumatoid arthritis |
| 15 | Hydroxychloroquine sulphate tablets 400 mg | Rheumatoid arthritis |
| 16 | Hydroxychloroquine sulphate tablets IP 200 mg | Rheumatoid arthritis |
| 17 | Linagliptin and Metformin Hydrochloride Tablets 2.5 mg and 500 mg | Diabetes |
| 18 | Linagliptin and Metformin Hydrochloride Tablets 2.5 mg and 850 mg | Diabetes |
| 19 | Linagliptin and Metformin Hydrochloride Tablets 2.5 mg and 1000 mg | Diabetes |
| 20 | Linagliptin tablets 5 mg | Diabetes |
| 21 | Metoprolol Succinate Extended-Release Tablets IP 25 mg | Blood Pressure and Heart |
| 22 | Metoprolol Succinate Extended-Release Tablets IP 50 mg | Blood Pressure and Heart |
| 23 | Metoprolol Succinate Extended-Release Tablets IP 100 mg | Blood Pressure and Heart |
| 24 | Metoprolol Succinate Extended-Release Tablets IP 200 mg | Blood Pressure and Heart |
| 25 | Pentoxifylline Extended-Release Tablets USP 400 mg | Leg Pain due to poor blood flow |
| 26 | Pravastatin Tablets IP 10 mg | Cholesterol |
| 27 | Pravastatin Tablets IP 20 mg | Cholesterol |
| 28 | Pravastatin Tablets IP 40 mg | Cholesterol |
| 29 | Procyclidine Hydrochloride tablets IP 2.5 mg | Parkinson’s |
| 30 | Procyclidine Hydrochloride tablets IP 5 mg | Parkinson’s |
| 31 | Propranolol Hydrochloride Extended-Release Capsules IP 80 mg | Blood Pressure |
| 32 | Ritonavir tablets IP 100 mg | Viral Infection (Part of Covid treatment) |
| 33 | Ritonavir tablets USP 100 mg | Viral Infection (Part of Covid treatment) |
| 34 | Sitagliptin and Metformin Hydrochloride tablets 50 mg and 500 mg | Diabetes |
| 35 | Sitagliptin and Metformin Hydrochloride tablets 50 mg and 850 mg | Diabetes |
| 36 | Sitagliptin and Metformin Hydrochloride tablets 50 mg and 1000 mg | Diabetes |
| 37 | Sitagliptin Tablets 25 mg | Diabetes |
| 38 | Sitagliptin Tablets 50 mg | Diabetes |
| 39 | Sitagliptin Tablets 100 mg | Diabetes |
| 40 | Sitagliptin tablets USP 100 mg | Diabetes |
| 41 | Telmisartan 20 mg + Amlodipine 2.5 mg + Hydrochlorothiazide 6.25 mg tablets | Blood Pressure |
| 42 | Telmisartan 20 mg + Amlodipine 2.5 mg + Hydrochlorothiazide 12.5 mg tablets | Blood Pressure |
| 43 | Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg tablets | Blood Pressure |
| 44 | Telmisartan 80 mg + Amlodipine 10 mg + Hydrochlorothiazide 25 mg tablets | Blood Pressure |
| 45 | Telmisartan and Amlodipine tablets IP 40 mg/5 mg | Blood Pressure |
| 46 | Telmisartan and Amlodipine tablets 40 mg/10 mg | Blood Pressure |
| 47 | Telmisartan and Amlodipine tablets 80 mg/5 mg | Blood Pressure |
| 48 | Telmisartan and Amlodipine tablets IP 80 mg/10 mg | Blood Pressure |
| 49 | Telmisartan and Hydrochlorothiazide tablets 40 mg/ 12.5 mg | Blood Pressure |
| 50 | Telmisartan and Hydrochlorothiazide tablets 80 mg/ 12.5mg | Blood Pressure |
| 51 | Telmisartan and Hydrochlorothiazide tablets 80 mg/ 25 mg | Blood Pressure |
| 52 | Telmisartan tablets 20 mg | Blood Pressure |
| 53 | Telmisartan tablets IP 40 mg | Blood Pressure |
| 54 | Telmisartan tablets IP 80 mg | Blood Pressure |
| 55 | Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz tablets IP 300 mg, 300 mg, 600 mg | Virus Infection |
| 56 | Tolvaptan Tablets 15 mg | Kidney Disease |
| 57 | Tolvaptan Tablets 30 mg | Kidney Disease |
| 58 | Ursodeoxycholic acid tablets 150 mg | Liver Disease |
| 59 | Ursodeoxycholic acid tablets 300 mg | Liver Disease |
| S.No |
Product Name (RLD used for Development) |
Markets Available for Out-licensing | Development Status | Development Status for India Market | |||||
|---|---|---|---|---|---|---|---|---|---|
| USA | EU | Canada | China | ROW | Others | ||||
| PRODUCTS READY FOR TECHNOLOGY TRANSFER | |||||||||
| 1 |
Esomeprazole Magnesium Delayed Release Tablets 20 and 40 mg (Nexium® from EU) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India |
| 2 |
Tenofovir Alafenamide Fumarate Tablets 25 mg (VEMLIDY® from USA) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Approved in India less than 4-years ago and considered as new drug. |
| 3 |
Ursodeoxycholic acid tablets 150, 250, 300, and 500 mg (Urso Falk® from USA and /Urso Forte® from EU) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 for 300 mg tablets is approved and can be launched in India. |
| 4 |
Ursodeoxycholic acid capsules 250, 300, and 450 mg (Actigall® from USA/Ursofalk® from Europe) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | It is not approved in India and considered as new drug. |
| 4 |
Pentoxifylline ER Tablets USP 400 mg (RLD is from AA Pharma Inc. Canada) |
✓ | ✓ | × | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 6 |
Guanfacine hydrochloride ER Tablets 1 mg, 2 mg, 3 mg and 4 mg (INTUNIV® from USA/EU/Canada) |
✓ | × | × | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | It is not approved in India and considered as new drug. |
| 7 |
Doxylamine succinate 10 mg and Pyridoxine HCl 10 mg DR tablets (Diclectin® from Canada) |
✓ | ✓ | × | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 8 |
Fingolimod Capsules 0.5 mg (Gilenya® from USA) |
✓ | × | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 9 | Procyclidine Tablets BP 2.5, 5, 15, 30 mg (Kemadrin® from EU) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India |
| 10 |
Lansoprazole Orally Disintegrating Tablets 15, 30 mg (TAKEPRON OD® from Japan and PREVACID® from EU) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | It is not approved in India and considered as new drug. |
| 11 |
Naftidrofuryl Capsules BP 100 mg (PRAXILINE® from EU and Taiwan) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | It is not approved in India and considered as new drug. |
| 12 |
Linagliptin Tablets 5 mg (TRADJENTA® from USA). |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 13 |
Sacubitril/ Valsartan tablets 24 mg/ 26 mg, 49 mg/ 51 mg, 97 mg/ 103 mg (ENTRESTO® from USA). |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 14 | Empagliflozin tablets 10 mg, 25 mg (JARDIANCE® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 15 |
Rosuvastatin Calcium tablets 5 mg, 10 mg, 20 mg, 40 mg (CRESTOR® from USA) |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development in progress and tech-transfer can be done in Sep-2022. | Form-25 available for launching in India. |
| 16 | Apixaban tablets 2.5 and 5 mg (ELIQUIS® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 17 | Sitagliptin tablets USP 25 mg, 50 mg, 100 mg (JANUVIA® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 18 | Sitagliptin and Metformin Hydrochloride tablets 50 mg/ 500 mg & 50 mg/ 1000 mg (JANUMET® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 19 | Tolvaptan Tablets 7.5, 15, 30, 45, 60, and 90 mg (Samsca®/Jinarc®/Jynarque® from EU/USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 20 | Linagliptin/Metformin HCl Tablets 2.5/500, 2.5/850, and 2.5/1000 mg (TRADJENTA DUO® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches. | Form-25 available for launching in India. |
| 21 | Empagliflozin/Metformin HCl Tablets 5/500 mg, 12.5/500, 5/1000, and 12.5/1000 mg (SYNJARDY® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 22 | Telmisartan/Amlodipine tablets 40 mg/5 mg, 40/10, 80/5, 80/10 mg (TWYNTA® from EU). | ✓ | ✓ | × | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches | Form-25 available for launching in India. |
| 23 | Telmisartan tablets 40 and 80 mg (MICARDIS HCT® from EU). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches. | Form-25 available for launching in India. |
| 24 | Naltrexone HCl 8 mg and Bupropion Hydrochloride 90 mg ER Tablets (Contrave® Extended-Release Tablets from USA and EU) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready tech-transfer and exhibit batches | It is not approved in India and considered as new drug. |
| 25 | Propranolol HCl ER Capsules USP 60, 80, 120, and 160 mg (INDERAL® LA from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready tech-transfer and exhibit batches. | Form-25 available for 80 mg strength for launching in India. |
| 26 | Metoprolol Succinate ER Tablets USP 25 mg, 50 mg, 100 mg and 200 mg (TOPROL XL® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development completed and ready for exhibit batches. | Form-25 available for all strengths for launching in India. |
| PRODUCTS UNDER DEVELOPMENT | |||||||||
| 27 | Telmisartan/Hydrochlorothiazide tablets 40/12.5, 80/12.5, and 80 mg/25 mg (MICARDIS HCT® from EU). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress | Form-25 available for launching in India. |
| 28 | Paroxetine ER Tablets USP 12.5 mg, 25 mg and 37.5 mg (Paxil CR® from USA/Seroxat CR® from EU) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 29 | Tolterodine Tartrate SR Capsules 2 mg and 4 mg (Detrol LA® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | It is not approved in India and considered as new drug. |
| 30 | Divalproex sodium ER Tablets 500 mg (DEPAKINE CHRONO® from EU) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in India. |
| 31 | Quetiapine Extended-Release Tablets 50, 200, 300, and 400 mg (Seroquel XR® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 32 | Aspirin /Extended-Release Dipyridamole Capsules 25 mg/200 mg (AGGRENOX® from EU) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 33 | Olanzapine Oro-dispersible Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg (CATALANT® /ZYPREXA VOLETAB® from EU and China) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Approved in India. Indivar need to apply for Form-25 for marketing. |
| 34 | Efavirenz/lamivudine/Tenofovir Disoproxil Fumarate Tablets 600/300/300 mg (SYMFI® from USA). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in india. |
| 35 | Edoxaban Tosylate tablets 15 mg, 30 mg, 60 mg (SAVAYSA®/ LIXIANA® from USA and EU). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | It is not Approved in India and considered as new drug. |
| 36 | Telmisartan/Amlodipine/ Hydrochlorothiazide tablets 80 mg/ 10 mg/25mg (MICARDIS TRIO® from JAPAN). | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in india. |
| Telmisartan/Amlodipine/Hydrochlorothiazide tablets 40 mg/5 mg/12.5 mg (MICARDIS TRIO® from JAPAN). | |||||||||
| Telmisartan/Amlodipine/ Hydrochlorothiazide tablets 20 mg/2.5 mg/12.5 mg (MICARDIS TRIO® from JAPAN). | |||||||||
| Telmisartan/Amlodipine/ Hydrochlorothiazide tablets 20 mg/2.5 mg/6.5 mg (MICARDIS TRIO® from JAPAN). | |||||||||
| 37 | Montelukast sodium chewable tablet 4 and 5 mg (SINGULAIR® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in india. |
| 38 | Montelukast sodium tablet 10 mg (SINGULAIR® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in india. |
| 39 | Amlodipine besylate and Atorvastatin calcium tablets 2.5/10, 2.5/20, 2.5/40, 5/20, 5/40, 5/80, 10/10, 10/20, 10/40, 10/80 mg (CADUET® from USA) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Development is in progress. | Form-25 available for launching in india. |
| S.NO. | NAME OF PRODUCT | CDSCO Approval date/ status | Valid till |
|---|---|---|---|
| 1 | Mesalamine DR Tablets USP 1.2 g | 18/Dec/2020 | |
| 2 | Pentosan Polysulfate Sodium Capsules 100 mg | 18/Dec/2020 | |
| 3 | Atorvastatin Calcium Tablets 10 mg, 20 mg, 40 mg and 80 mg | 21/Feb/2021 | |
| 4 | Methazolamide Tablets USP 25 mg and 50 mg | Unapproved | 21/Feb/2021 |
| 5 | Naltrexone HCl 8 mg and Bupropion Hydrochloride 90 mg ER Tablets | Unapproved | 21/Feb/2021 |
| 6 | Propranolol HCl ER Capsules USP 80 mg | 21/Feb/2021 | |
| 7 | Metoprolol Succinate ER Tablets USP 25 mg, 50 mg, 100 mg and 200 mg | 8/Apr/2021 | |
| 8 | Albendazole Tablets 400 mg | 18/Apr/2021 | |
| 9 | Propranolol HCl ER Capsules USP 60 mg, 120 mg and 160 mg | Unapproved | 18/Apr/2021 |
| 10 | Aspirin SR Capsules 162.5 mg | Unapproved | 29/May/2021 |
| 11 | Paroxetine ER Tablets USP 12.5 mg, 25 mg and 37.5 mg | Unapproved | Unapproved |
| 12 | Tolterodine Tartrate SR Capsules 2 mg and 4 mg | Unapproved | 29/May/2021 |
| 13 | Tenofovir Alafenamide Tablets 25 mg | Unapproved | 21/May/2021 |
| 14 | Ursodeoxycholic acid tablets 150 mg | 12/Apr/2001 | 21/May/2021 |
| 15 | Ursodeoxycholic acid tablets 300 mg | 12/Apr/2001 | 21/May/2021 |
| 16 | Pregabalin ER Tablets 82.5 mg, 165 mg and 330 mg | Unapproved | 29/May/2021 |
| 17 | 29/May/2021 | 10/Feb/2011 | 10/Jun/2021 |
| 18 | Divalproex sodium ER Tablets 500 mg | 1/Aug/2004 | 13/Jun/2021 |
| 19 | Sodium valproate CR Tablets 750 mg | 24/Jan/2008 | 13/Jun/2021 |
| 20 | Sodium valproate CR Tablets 1000 mg | 24/Jan/2008 | 13/Jun/2021 |
| 21 | Enrofloxacin Tablets 15 mg, 50 mg and 150 mg | Unapproved | 6/Jul/2021 |
| 22 | Pentoxifylline ER Tablets USP 400 mg | 1/Mar/1990 | 18/Jul/2021 |
| 23 | 18/Jul/2021 | 26/Jun/2000 | 18/Jul/2021 |
| 24 | Irbesartan Tablets 150 mg | 26/Jun/2000 | 18/Jul/2021 |
| 25 | Guanfacine hydrochloride ER Tablets 1 mg, 2 mg, 3 mg and 4 mg | Unapproved | 1/Aug/2021 |
| 26 | Doxylamine succinate 10 mg and Pyridoxine HCl 10 mg DR tablets | Unapproved | 17/Aug/2021 |
| 27 | Amlodipine & valsartan USP Tablets 5 mg/80 mg | 21/Feb/2007 | 20/Aug/2021 |
| 28 | Amlodipine & valsartan USP Tablets 5 mg/160 mg | 21/Feb/2007 | 20/Aug/2021 |
| 29 | Ivabradine Tablets 5 mg | 3/Jul/2008 | 20/Aug/2021 |
| 30 | Ivabradine Tablets 7.5 mg | 3/Jul/2008 | 20/Aug/2021 |
| 31 | Quetiapine Extended Release Tablets 50 mg | 10/Apr/2007 | 10/Apr/2007 |
| 32 | Quetiapine Extended Release Tablets 200 mg | 1/Aug/2006 | 20/Aug/2021 |
| 33 | Quetiapine Extended Release Tablets 300 mg | 1/Aug/2006 | 20/Aug/2021 |
| 34 | Quetiapine Extended Release Tablets 400 mg | 5/Mar/2007 | 20/Aug/2021 |
| 35 | Sevelamer Carbonate Tablets 800 mg | 28/Apr/2008 | 20/Aug/2021 |
| 36 | Sirolimus Tablets 1 mg | 31/Dec/2002 | 20/Aug/2021 |
| 37 | Fingolimod Capsules 0.5 mg | Unapproved | 20/Aug/2021 |
| 38 | Aspirin /Extended Release Dipyridamole Capsules 25 mg/200 mg | 27/Feb/2003 | 30/Aug/2021 |
| 39 | Duloxetine Delayed Release Capsules USP 20 mg, 30 mg, 60 mg | 2/Mar/2005 | 30/Aug/2021 |
| 40 | Gefitinib Tablets 250 mg | 18/Dec/2009 | |
| 41 | Cholestyramine for oral suspension 4 g/sachet | 30/Mar/2006 | |
| 42 | Olanzapine Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg | 27/Jan/2000 | 14/Oct/2021 |
| 43 | Olanzapine Tablets 15 mg | 18/Jan/2002 | 14/Oct/2021 |
| 44 | 14/Oct/2021 | 23/Jul/1999 | |
| 45 | Olanzapine ODTs 10 mg & 5 mg | Unapproved | 4/Dec/2021 |
| 46 | Ursodeoxycholic acid Capsules 250 mg, 300 mg and 450 mg Ursodeoxycholic acid Tablets 250 mg and 500 mg | Unapproved | 4/Dec/2021 |
| 47 | Sirolimus Tablets 0.5 mg | Unapproved | 4/Dec/2021 |
| 48 | BAR502 (CAS#1612191-86-2) Tablets 50 mg, 100 mg, 150 mg, 200 mg, 250 mg, 300 mg | Unapproved | 4/Jan/2022 |
| 49 | Aspirin DR Tablets 25 mg, 75 mg, 81 mg, 100 mg | Unapproved | 4/Jan/2022 |
| 50 | Indapamide Tablets BP 2.5 mg | 1/Nov/1978 | 4/Jan/2022 |
| 51 | Lisinopril Tablets BP 5, 10, 20 mg | 1/Nov/1991 | 4/Jan/2022 |
| 52 | Risedronate sodium tablets USP 35 mg | 8/Oct/2007 | 4/Jan/2022 |
| 53 | Risedronate sodium tablets USP 150 mg | 16/Sep/2008 | 4/Jan/2022 |
| 54 | Procyclidine Tablets BP 2.5 , 5mg | IP2010 | 4/Jan/2022 |
| 55 | Procyclidine Tablets BP 15, 30 mg | Unapproved | 4/Jan/2022 |
| 56 | Candesartan Cilexetil Tablets USP 8, 16 mg | 31/Aug/2000 | 4/Jan/2022 |
| 57 | Pravastatin Tablets BP 10, 20, 40 mg | 20/Dec/2000 | 4/Jan/2022 |
| 58 | Esomeprazole mg DR Tablets 20, 40 mg | 6/Apr/2011 | 4/Jan/2022 |
| 59 | Atenolol Tablets 50, 100 mg | 1/Sep/1985 | 4/Jan/2022 |
| 60 | Imipramine Tablets 10, 25 mg | IP2010 | 4/Jan/2022 |
| 61 | Clomipramine Tablets 10, 25, 50 mg | 1/Feb/1992 | 24/Jan/2022 |
| 62 | Doxepin Capsules BP 10, 25, 50 mg | 1/Sep/1972 | 24/Jan/2022 |
| 63 | Ibuprofen SR Capsules 300, 400 mg | 1/Mar/1990 | 24/Jan/2022 |
| 64 | Omeprazole DR Capsules USP 20 mg | 1/Apr/1991 | 24/Jan/2022 |
| 65 | Clonazepam Tablets BP 0.25 mg | 5/Jul/2001 | 24/Jan/2022 |
| 66 | Clonazepam Tablets BP 0.5, 1, 2 mg | 25/Jan/1995 | 24/Jan/2022 |
| 67 | Azithromycin Tablets BP 250 mg | 6/Mar/2013 | 24/Jan/2022 |
| 68 | Paroxetine Tablets BP 10, 20, 30, 40 mg | 4/Oct/2000 | 24/Jan/2022 |
| 69 | Candesartan Cilexetil Tablets USP 4 mg | 31/Aug/2000 | 24/Jan/2022 |
| 70 | Citalopram Tablets 30 mg | Unapproved | 24/Jan/2022 |
| 71 | Diphenoxylate Hydrochloride and Atropine Sulfate Tablets USP 2.5 mg / 0.025 mg | 1/Jun/1969 | 24/Jan/2022 |
| 72 | Indapamide Tablets BP 1.25 mg | Unapproved | 24/Jan/2022 |
| 73 | Lamotrigine Tablets BP 25mg | 14/May/1998 | 24/Jan/2022 |
| 74 | Lamotrigine Tablets BP 100 mg | 21/Jan/2000 | 24/Jan/2022 |
| 75 | Lansoprazole Orally Disintegrating Tablets 15, 30 mg | Unapproved | 24/Jan/2022 |
| 76 | Lisinopril Tablets BP 40 mg | Unapproved | 24/Jan/2022 |
| 77 | Naftidrofuryl Capsules BP 100 mg | Unapproved | 24/Jan/2022 |
| 78 | Omeprazole DR capsules USP 40 mg | Unapproved | 19/Feb/2022 |
| 79 | Atenolol Tablets BP 25 mg | Unapproved | 19/Feb/2022 |
| 80 | Imipramine Tablets BP 50 mg, 75 mg | Unapproved | 19/Feb/2022 |
| 81 | Risedronate Sodium Tablets USP 5, 30, 75 mg | Unapproved | 19/Feb/2022 |
| 82 | Acarbose Tablets USP 50 mg, 100 mg | 6/Mar/1997 | 19/Feb/2022 |
| 83 | Eltrombopag Olamine Tablets 25 mg, 50 mg | 19/Oct/2010 | 19/Feb/2022 |
| 84 | Bisoprolol Fumarate Tablets USP 2.5 mg | 19/Jan/2001 | 22/May/2022 |
| 85 | Bisoprolol Fumarate Tablets USP 5 mg and 10 mg | 27/Feb/1992 | 22/May/2022 |
| 86 | Mirtazapine Tablets USP 15 mg, 30 mg and 45 mg | 13/Feb/2001 | 22/May/2022 |
| 87 | Mycophenolate Mofetil Tablets USP 500 mg | 7/Feb/1999 | 22/May/2022 |
| 88 | Oxcarbazepine Tablets USP 150 mg, 300 mg and 600 mg | 14/Jan/2002 | 22/May/2022 |
| 89 | Imatinib Tablets IP 100 mg | 26/Feb/2005 | 6/Jun/2022 |
| 90 | Imatinib Tablets IP 400 mg | 5/Apr/2010 | 6/Jun/2022 |
| 91 | Erlotinib Tablets IP 25 mg, 100 mg, 150 mg | 21/Jul/2005 | 6/Jun/2022 |
| 92 | Gefitinib Tablets 250 mg | 18/Dec/2009 | 6/Jun/2022 |
| 93 | Canagliflozin Tablets 100 mg, 300 mg | 17/Nov/2014 | 6/Jun/2022 |
| 94 | Linagliptin Tablets 5 mg | 23/Jan/2012 | 6/Jun/2022 |
| 95 | Vildagliptin Tablets 50 mg, 100 mg | 18/Jan/2008 | 6/Jun/2022 |
| 96 | Tadalafil Tablets USP 2.5 mg, 5 mg | 27/Feb/2013 | 23/Jul/2022 |
| 97 | Tadalafil Tablets USP 10 mg and 20 mg | 11/Sep/2003 | 23/Jul/2022 |
| 98 | Sapropterin Dihydrochloride Tablets 100 mg | Unapproved | 23/Jul/2022 |
| 99 | Desloratadine Syrup 0.5 mg/ml | Unapproved | 23/Jul/2022 |
| 100 | Dapoxetine hydrochloride tablets 30 mg and 60 mg | 15/Nov/2010 | 23/Jul/2022 |
| 101 | Abiraterone acetate tablets 250 mg | 16/Dec/2011 | 23/Jul/2022 |
| 102 | Lopinavir/Ritonavir USP Tablets 100/25 mg | 8/Sep/2008 | 23/Jul/2022 |
| 103 | Lopinavir/Ritonavir USP Tablets 200/50 mg | 8/Jun/2006 | 23/Jul/2022 |
| 104 | Efavirenz/lamivudine/Tenofovir Disoproxil Fumarate Tablets 600/300/300 mg | 23/Jul/2008 | 23/Jul/2022 |
| 105 | Sacubitril/ Valsartan tablets 24 mg/ 26 mg, 49 mg/ 51 mg, 97 mg/ 103 mg | Unapproved | 25/Aug/2022 |
| 106 | Empagliflozin tablets 10 mg, 25 mg | 7/May/2015 | 25/Aug/2022 |
| 107 | Rosuvastatin Calcium tablets 5 mg, 10 mg, 20 mg, 40 mg | 8/Nov/2008 | 25/Aug/2022 |
| 108 | Apixaban tablets 2.5 mg | 3/Aug/2012 | 25/Aug/2022 |
| 109 | Apixaban tablets 5 mg | 16/May/2014 | 25/Aug/2022 |
| 110 | Sitagliptin tablets USP 25 mg, 50 mg, 100 mg | 31/Oct/2007 | 25/Aug/2022 |
| 111 | Sitagliptin and Metformin Hydrochloride tablets 50 mg/ 500 mg & 50 mg/ 1000 mg | 24/Apr/2008 | 25/Aug/2022 |
| 112 | Dasatinib tablets 100 mg | 10/Jul/2009 | 25/Aug/2022 |
| 113 | Pazopanib tablets 200 mg | 19/Oct/2010 | 25/Aug/2022 |
| 114 | Sunitinib Malate Capsules 50 mg | 11/Apr/2007 | 25/Aug/2022 |
| 115 | Acetaminophen Extended Release tablets USP 650 mg | 1996 | 25/Aug/2022 |
| 116 | Obeticholic acid Tablets 5 mg & 10 mg | Unapproved | 10/Sep/2022 |
| 117 | Fingolimod Capsules 0.25 mg | Unapproved | 10/Sep/2022 |
| 118 | Capecitabine tablets USP 150 mg & 500 mg | 12/Oct/2000 | 10/Sep/2022 |
| 119 | 12/Oct/2000 | Unapproved | 2/Oct/2022 |
| 120 | Elagolix Tablets 150 mg | Unapproved | 2/Oct/2022 |
| 121 | Elagolix Tablets 200 mg | Unapproved | 2/Oct/2022 |
| 122 | Tolvaptan Tablets 15 mg | 6/Sep/2012 | 2/Oct/2022 |
| 123 | Tolvaptan Tablets 30 mg | 6/Sep/2012 | 2/Oct/2022 |
| 124 | Tenofovir Disoproxil Fumarate/ Emtricitabine/ Efavirenz tablets 300 mg/ 200 mg/ 600 mg | 1/Aug/2006 | 2/Oct/2022 |
| 125 | Abiraterone acetate tablets 500 mg | Unapproved | 14/Oct/2022 |
| 126 | Edoxaban tosylate tablets 15 mg, 30 mg, 60 mg | Unapproved | 28/Oct/2022 |
| 127 | Linagliptin/ Metformin HCl Tablets 2.5/500 mg, Linagliptin/ Metformin HCl Tablets 2.5/850 mg, Linagliptin/ Metformin HCl Tablets 2.5/1000 mg | Unapproved | 7/Nov/2022 |
| 128 | Empagliflozin/ Metformin HCl Tablets 5/500 mg, Empagliflozin/ Metformin HCl Tablets 5/1000 mg, Empagliflozin/ Metformin HCl Tablets 12.5/500 mg Empagliflozin/ Metformin HCl Tablets 12.5/1000 mg | Unapproved | 7/Nov/2022 |
| 129 | Sitagliptin and Metformin Hydrochloride tablets 50 mg/ 850 mg | 2/Aug/2010 | 7/Nov/2022 |
| 130 | Telmisartan/Amlodipine tablets 40 mg/5 mg | 30/Aug/2006 | 22/Nov/2022 |
| 131 | Telmisartan/Amlodipine tablets 80 mg/5 mg | 30/Mar/2009 | 22/Nov/2022 |
| 132 | Telmisartan/Amlodipine tablets 40 mg/10 mg | 22/May/2008 | 22/Nov/2022 |
| 133 | Telmisartan/Amlodipine tablets 80 mg/10 mg | 31/May/2011 | 22/Nov/2022 |
| 134 | Telmisartan/Hydrochlorothiazide tablets 80 mg/25 mg | 14/May/2003 | 22/Nov/2022 |
| 135 | Telmisartan/Hydrochlorothiazide tablets 40 mg/12.5 mg | 29/Aug/2003 | 22/Nov/2022 |
| 136 | Telmisartan/Hydrochlorothiazide tablets 80 mg/12.5 mg | 29/Aug/2003 | 22/Nov/2022 |
| 137 | Telmisartan tablets 40 mg | 25/Nov/2002 | 11/Feb/2023 |
| 138 | Telmisartan tablets 80 mg | 25/Nov/2002 | 11/Feb/2023 |
| 139 | Raltegravir tablets 400 mg | 27/Jan/2010 | 11/Feb/2023 |
| 140 | Atenolol tablets 50 mg , 100 mg | Sep 1985 | 1/Mar/2023 |
| 141 | Dolutegravir, Lamivudine and TDF tablets 50/300/300 mg | Unapproved | 1/Mar/2023 |
| 142 | Efavirenz, Lamivudine and TDF tablets 400/300/300 mg | Unapproved | 1/Mar/2023 |
| 143 | Carvedilol tablets USP 12.5, 25 mg | 16/Oct/1998 | 23/Mar/2023 |
| 144 | Carvedilol tablets USP 3.125, 6.25 mg | 10/Mar/1999 | 23/Mar/2023 |
| 145 | Edaravone Injection 1.5 mg/mL | 27/Jul/2007 | 23/Mar/2023 |
| 146 | Ciprofloxacin tablets 250 mg, 500 mg, 750 mg | may 1989 | 7/Apr/2023 |
| 147 | Hydroxychloroquine sulphate tablets 300 mg | 9/Aug/2014 | 16/Apr/2023 |
| 148 | Hydroxychloroquine sulphate tablets 400 mg | 31/Jan/2008 | 16/Apr/2023 |
| 149 | Hydroxychloroquine sulphate tablets 200 mg | 26/Jun/2016 | 16/Apr/2023 |
| 150 | Dexamethasone tablets 4 mg | 2/Nov/2004 | 16/Apr/2023 |
| 151 | Dexamethasone tablets 8 mg | 2/Nov/2004 | 16/Apr/2023 |
| 152 | Ketorolac Tromethamine tablets 10 mg | 21/Apr/1992 | 16/Apr/2023 |
| 153 | Fluvoxamine maleate tablets 50 mg | 21/Feb/2000 | 16/Apr/2023 |
| 154 | Fluvoxamine maleate tablets 100 mg | 21/Feb/2000 | 16/Apr/2023 |
| 155 | Everolimus tablets 2.5 mg | 21/Mar/2013 | 17/May/2023 |
| 156 | Everolimus tablets 5 mg | 16/May/2009 | 17/May/2023 |
| 157 | Everolimus tablets 10 mg | 16/May/2009 | 17/May/2023 |
| 158 | Nilotinib Capsules 150 mg | 29/Sep/2010 | 17/May/2023 |
| 159 | Nilotinib Capsules 200 mg | 14/Jul/2010 | 17/May/2023 |
| 160 | Ticagrelor tablets 90 mg | 3/May/2012 | 26/May/2023 |
| 161 | Tolvaptan tablets 7.5 mg | Unapproved | 26/May/2023 |
| 162 | Tolvaptan tablets 45 mg | Unapproved | 18/Aug/2026 |
| 163 | Tolvaptan tablets 60 mg | Unapproved | 26/May/2023 |
| 164 | Tolvaptan tablets 90 mg | Unapproved | 26/May/2023 |
| 165 | Dexamethasone tablets 2 mg | Unapproved | 26/May/2023 |
| 166 | Dexamethasone tablets 6 mg | Unapproved | 26/May/2023 |
| 167 | Metformin HCl tablets 500 mg , 850 mg | IP 2010 | 26/May/2023 |
| 168 | Ramipril capsules 1.25, 2.5, 5, 10 mg | 2005 | 23/Jun/2023 |
| 169 | Gabapentin capsules 300, 400 mg | 3/Aug/1995 | 23/Jun/2023 |
| 170 | Ibuprofen tablets 200 mg, 400mg, 600mg | IP2010 | 4/Aug/2023 |
| 171 | Telmisartan/Amlodipine/ Hydrochlorothaizide tablets 80 mg/ 10 mg/25mg | 12/Oct/2010 | 23/Sep/2023 |
| 172 | Telmisartan/Amlodipine/Hydrochlorothaizide tablets 40 mg/5 mg/12.5mg | 12/Oct/2010 | 23/Sep/2023 |
| 173 | Telmisartan/Amlodipine/ Hydrochlorothaizide tablets 20 mg/2.5 mg/12.5mg | 12/Oct/2010 | 23/Sep/2023 |
| 174 | Telmisartan/Amlodipine/ Hydrochlorothaizide tablets 20 mg/2.5 mg/6.25 mg | 3/Jan/2013 | 23/Sep/2023 |
| 175 | Rosuvastatin calcium tablets 5, 10, 20, 40 mg | 8/Nov/2008 | 27/Oct/2023 |
| 176 | Montelukast sodium chewable tablet 4, 5 mg | 13/Feb/2002 | 27/Oct/2023 |
| 177 | Montelukast sodium tablet 10 mg | sep 2004 | 27/Oct/2023 |
| 178 | Saxogliptin tablets 2.5 mg | 26/Oct/2009 | 7/Dec/2023 |
| 179 | Saxogliptin tablets 5 mg | 26/Oct/2009 | 7/Dec/2023 |
| 180 | Metformin (ER) and Saxagliptin tablets 1000 mg/ 2.5 mg | 19/Sep/2011 | 7/Dec/2023 |
| 181 | Metformin (ER) and Saxagliptin tablets 500 mg/ 5 mg | 19/Sep/2011 | 7/Dec/2023 |
| 182 | Rivaroxaban tablets 2.5 mg | 13/Jul/2015 | 7/Dec/2023 |
| 183 | Rivaroxaban tablets 10 mg | 13/Feb/2010 | 7/Dec/2023 |
| 184 | Rivaroxaban tablets 15 mg | 2/Sep/2014 | 7/Dec/2023 |
| 185 | Rivaroxaban tablets 20 mg | 2/Sep/2014 | 7/Dec/2023 |
| 186 | Dapagliflozin tablets 5 mg | 25/Feb/2015 | 7/Dec/2023 |
| 187 | Dapagliflozin tablets 10 mg | 25/Feb/2015 | 7/Dec/2023 |
| 188 | Acetaminophen and Ibuprofen tablets 250/125 mg | Unapproved | 4/Jan/2024 |
| 189 | Orlistat capsules 60 mg | 1/Jun/2009 | 5/Feb/2024 |
| 190 | Orlistat capsules 120 mg | 22/Aug/2007 | 5/Feb/2024 |
| 191 | Sildenafil citrate orally disintegrating tablets 25 mg | 8/Jan/2001 | 5/Feb/2024 |
| 192 | Sildenafil citrate orally disintegrating tablets 50 mg | 8/Jan/2001 | 5/Feb/2024 |
| 193 | Nintedanib soft gelatin capsules 100 mg | 11/Mar/2016 | 5/Feb/2024 |
| 194 | Nintedanib soft gelatin capsules 150 mg | 11/Mar/2016 | 5/Feb/2024 |
| 195 | Procyclidine Hydrochloride tablets 10 mg | Unapproved | 18/Feb/2024 |
| 196 | Ramipril capsules 15 mg | Unapproved | 18/Feb/2024 |
| 197 | Vildagliptin tablets 50 mg | 18/Jan/2008 | 18/Feb/2024 |
| 198 | Vildagliptin tablets 100 mg | 18/Jan/2008 | 18/Feb/2024 |
| 199 | Vildagliptin tablets 100 mg | 21/Jul/2008 | 18/Feb/2024 |
| 200 | Vildagliptin and Metformin Hydrochloride tablets 50 mg/ 850 mg | 21/Jul/2008 | 18/Feb/2024 |
| 201 | Vildagliptin and Metformin Hydrochloride tablets 50 mg/ 1000 mg | 21/Jul/2008 | 18/Feb/2024 |
| 202 | Atorvastatin Calcium Tablets 10 mg, 20 mg, 40 mg | 17/Sep/1999 | 8/Mar/2024 |
| 203 | Atorvastatin Calcium Tablets 80 mg | 25/Feb/2008 | 8/Mar/2024 |
| 204 | Amlodipine besylate and Atorvastatin calcium tablets 2.5/10 mg | 10/Feb/2004 | 8/Mar/2024 |
| 205 | Amlodipine besylate and Atorvastatin calcium tablets 5/10 mg | 11/Feb/2004 | 8/Mar/2024 |
| 206 | Carbamazepine tablets 200 mg | IP2010 | 8/Mar/2024 |
| 207 | Dicyclomine tablets 20 mg | IP2010 | 8/Mar/2024 |
| 208 | Amlodipine besylate and Atorvastatin calcium tablets 2.5/20 mg | Unapproved | 25/Apr/2024 |
| 209 | Amlodipine besylate and Atorvastatin calcium tablets 2.5/40 mg | Unapproved | 25/Apr/2024 |
| 210 | Amlodipine besylate and Atorvastatin calcium tablets 5/20 mg | Unapproved | 25/Apr/2024 |
| 211 | Amlodipine besylate and Atorvastatin calcium tablets 5/40 mg | Unapproved | 25/Apr/2024 |
| 212 | Amlodipine besylate and Atorvastatin calcium tablets 5/80 mg | Unapproved | 25/Apr/2024 |
| 213 | Amlodipine besylate and Atorvastatin calcium tablets 10/10 mg | Unapproved | 25/Apr/2024 |
| 214 | Amlodipine besylate and Atorvastatin calcium tablets 10/20 mg | Unapproved | 25/Apr/2024 |
| 215 | Amlodipine besylate and Atorvastatin calcium tablets 10/40 mg | Unapproved | 25/Apr/2024 |
| 216 | Amlodipine besylate and Atorvastatin calcium tablets 10/80 mg | Unapproved | 25/Apr/2024 |
| 217 | Pazopanib tablets 400 mg | 19/Oct/2010 | 25/Apr/2024 |
| 218 | Itopride Hydrochloride tablets 50 mg | 9/May/2002 | 25/Apr/2024 |
| 219 | Enzalutamide tablets 40 mg | Unapproved | 25/Apr/2024 |
| 220 | Enzalutamide tablets 80 mg | Unapproved | 25/Apr/2024 |
| 221 | Bosutinib tablets 100 mg | Unapproved | 25/Apr/2024 |
| 222 | Palbociclib tablets 125 mg | Unapproved | 12/May/2024 |
| 223 | Tofacitinib ER tablets 22 mg | Unapproved | 23/May/2024 |
| 224 | Ursodeoxycholic acid tablets 100 mg | Unapproved | 23/May/2024 |
| 225 | Ursodeoxycholic acid tablets 200 mg | Unapproved | 23/May/2024 |
| 226 | Amlodipine tablet 5 mg | 15/Jun/2024 | |
| 227 | Amlodipine tablet 10 mg | 15/Jun/2024 | |
| 228 | Azithromycin tablets 250 mg | 15/Jun/2024 | |
| 229 | Azithromycin tablets 500 mg | 15/Jun/2024 | |
| 230 | Azithromycin tablets 500 mg | 15/Jun/2024 | |
| 231 | Fexofenadine Hydrochloride tablets 180 mg | 15/Jun/2024 | |
| 232 | Salbutamol tablets 4 mg | 15/Jun/2024 | |
| 233 | Famotidine for oral suspension 40mg/ 5 mL | 15/Jun/2024 | |
| 234 | Ursodeoxycholic acid tablets 300 mg | 15/Jun/2024 | |
| 235 | Aceclofenac and Paracetamol tablets 100 mg/500 mg | 15/Jun/2024 | |
| 236 | Fexofenadine Hydrochloride and Montelukast tablets 120mg/ 10 mg | 15/Jun/2024 | |
| 237 | Glimepiride tablets 1 mg | 15/Jun/2024 | |
| 238 | Glimepiride tablets 2 mg | 15/Jun/2024 | |
| 239 | Glimepiride tablets 3 mg | 15/Jun/2024 | |
| 240 | Glimepiride tablets 4 mg | 15/Jun/2024 | |
| 241 | Glimepiride and Metformin Hydrochloride Sustained release tablet 1 mg/500 mg | 15/Jun/2024 | |
| 242 | Glimepiride and Metformin Hydrochloride Sustained release tablet 2 mg/ 500 mg | 15/Jun/2024 | |
| 243 | Glimepiride and Metformin Hydrochloride Sustained release tablet 1 mg/1000 mg | 15/Jun/2024 | |
| 244 | Glimepiride and Metformin Hydrochloride Sustained release tablet 2 mg/ 1000 mg | 15/Jun/2024 | |
| 245 | Pantoprazole Gastro Resistant tablets 40 mg | 15/Jun/2024 | |
| 246 | Rebamipide tablets 100 mg | 30/Jun/2024 | |
| 247 | Felodipine Extended Release tablets 5 mg | 30/Jun/2024 | |
| 248 | Felodipine Extended Release tablets 10 mg | 30/Jun/2024 | |
| 249 | Pantoprazole gastro resistant 40 mg and Domperidone prolonged release 30 mg capsules IP | 30/Jun/2024 | |
| 250 | Pantoprazole gastro resistant 40 mg and Domperidone prolonged release 10 mg capsules | 30/Jun/2024 | |
| 251 | Pantoprazole gastro resistant 20 mg and Domperidone prolonged release 30 mg capsules | 30/Jun/2024 | |
| 252 | Omeprazole gastro resistant 20 mg and Domperidone sustained release 30 mg capsules | 30/Jun/2024 | |
| 253 | Esomeprazole 20 mg and Domperidone sustained release 30 mg capsules | 30/Jun/2024 | |
| 254 | Esomeprazole 40 mg and Domperidone sustained release 30 mg capsules | 30/Jun/2024 | |
| 255 | Itraconazole capsules 100 mg | 30/Jun/2024 | |
| 256 | Aceclofenac 100 mg and Paracetamol 325 mg tablets | 30/Jun/2024 | |
| 257 | Amlodipine besylate tablet 2.5 mg | 19/May/1993 | 29/Jul/2024 |
| 258 | Levocetrizine dihydrochloride tablets 5 mg | IP2010 | 29/Jul/2024 |
| 259 | Montelukast sodium and levocetrizine dihydrochloride tabelts 10mg / 5 mg | 31/Jan/2008 | 29/Jul/2024 |
| 260 | Desloratidine tablets 5 mg | 14/Jan/2002 | 29/Jul/2024 |
| 261 | Montelukast sodium and Desloratidine tablets 10 mg and 5 mg | 10/Nov/2008 | 29/Jul/2024 |
| 262 | Ibuprofen and Glucosamine sulfate tablets 200mg + 500 mg | 3/Nov/2009 | 29/Jul/2024 |
| 263 | ibuprofen and chlorozoxazone tablets 400 mg + 500 mg | 7/Apr/2010 | 29/Jul/2024 |
| 264 | Ibuprofen and Paracetamol tablets 400 mg and 325 mg | Oct 1984 | 29/Jul/2024 |
| 265 | Aceclofenac tablets 100 mg | 5/Apr/2007 | 29/Jul/2024 |
| 266 | Gliclazide tablets 80 mg | nov 1998 | 29/Jul/2024 |
| 267 | Pioglitazone tablets 15 mg | 17/Oct/2000 | 1/Aug/2024 |
| 268 | Pioglitazone tablets 30 mg | 17/Oct/2000 | 1/Aug/2024 |
| 269 | Pioglitazone tablets 45 mg | 17/Oct/2000 | 1/Aug/2024 |
| 270 | Metformin HCl Sustained release tablets 500 mg | 9/Nov/2001 | 1/Aug/2024 |
| 271 | Metformin HCl Sustained release tablets 1000 mg | 2002 | 1/Aug/2024 |
| 272 | Glibenclamide/ Metfromin HCl SR tablets 2.5mg / 500 mg | 20/Aug/2004 | 1/Aug/2024 |
| 273 | Glibenclamide/ Metfromin HCl SR tablets 5mg / 500 mg | 20/Aug/2004 | 1/Aug/2024 |
| 274 | Glibenclamide/ Metfromin HCl SR tablets 5mg / 850 mg | 15/Feb/2007 | 1/Aug/2024 |
| 275 | Pioglitazone/ Metformin HCl SR tablets 15mg/ 1000 mg | 23/Jan/2007 | 1/Aug/2024 |
| 276 | Pioglitazone/ Metformin HCl SR tablets 30mg/ 1000 mg | 23/Jan/2007 | 1/Aug/2024 |
| 277 | Atorvastatin calcium and Metoprolol succinate Extended release tablets 10mg/ 25 mg | 28/Jan/2008 | 1/Aug/2024 |
| 278 | Atorvastatin calcium and Metoprolol succinate Extended release tablets 10mg/ 50 mg | 28/Jan/2008 | 1/Aug/2024 |
| 279 | Atorvastatin calcium and Ezetimibe tablets 10mg/ 10 mg | 13/Aug/2004 | 1/Aug/2024 |
| 280 | Atorvastatin calcium and Ezetimibe tablets 20mg/ 10 mg | 13/Aug/2004 | 1/Aug/2024 |
| 281 | Atorvastatin calcium and Ezetimibe tablets 40mg/ 10 mg | 30/Jul/2007 | 1/Aug/2024 |
| 282 | Atorvastatin calcium and Aspirin capsules 10mg/ 75 mg | 18/Jan/2008 | 1/Aug/2024 |
| 283 | Atorvastatin calcium and Aspirin capsules 10mg/ 150 mg | 18/Jan/2008 | 1/Aug/2024 |
| 284 | Mesalamine Delayed Release Tablets USP 1.2 g | 27/Aug/2024 | |
| 285 | Tenofovir Alafenamide Tablets 25 mg | Unapproved | 27/Aug/2024 |
| 286 | Paracetamol Fast Release Tablets 500 mg | 27/Aug/2024 | |
| 287 | Rosuvastatin 5 mg and Clopidogrel 75 mg capsules | 26/Aug/2024 | |
| 288 | Rosuvastatin 10 mg and Clopidogrel 75 mg capsules | 26/Aug/2024 | |
| 289 | Rosuvastatin 20 mg and Clopidogrel 75 mg capsules | 26/Aug/2024 | |
| 290 | Atorvastatin Calcium 10mg and Clopidogrel 75mg capsules | 26/Aug/2024 | |
| 291 | Atorvastatin Calcium 20mg and Clopidogrel 75mg capsules | 26/Aug/2024 | |
| 292 | Rupatadine tablets 10 mg | 17/Sep/2024 | |
| 293 | Rupatadine 10 mg and Montelukast 10 mg tablets | 17/Sep/2024 | |
| 294 | Levocetrizine Dihydrochloride Dispersible tablets 5 mg | 17/Sep/2024 | |
| 295 | Levocetrizine Dihydrochloride Dispersible tablets 10 mg | 17/Sep/2024 | |
| 296 | Rosuvastatin 5 mg and Aspirin tablets 75 mg | 17/Sep/2024 | |
| 297 | Rosuvastatin 10 mg and Aspirin tablets 75 mg | 17/Sep/2024 | |
| 298 | Rosuvastatin 10 mg and Aspirin tablets 150 mg | 17/Sep/2024 | |
| 299 | Rosuvastatin 5 mg and Clopidogrel 75 mg film coated tablets | 17/Sep/2024 | |
| 300 | Rosuvastatin 10 mg and Clopidogrel 75 mg film coated tablets | 17/Sep/2024 | |
| 301 | Atorvastatin 5mg and Fenofibrate 145mg tablet | 17/Sep/2024 | |
| 302 | Atorvastatin 5mg and Fenofibrate 160mg | 17/Sep/2024 | |
| 303 | Atorvastatin 10mg and Fenofibrate 80mg tablet | 17/Sep/2024 | |
| 304 | Atorvastatin 10mg and Fenofibrate 145mg tablet | 17/Sep/2024 | |
| 305 | Atorvastatin 10 mg and Fenofibrate 160mg tablets | 17/Sep/2024 | |
| 306 | Atorvastatin 10mg and Fenofibrate 200mg tablet | 17/Sep/2024 | |
| 307 | Atorvastatin 20mg and Fenofibrate 160mg tablets | 17/Sep/2024 | |
| 308 | Oxazepam tablets 10 mg | 17/Sep/2024 | |
| 309 | Oxazepam tablets 15 mg | 17/Sep/2024 | |
| 310 | Oxazepam tablets 30 mg | 17/Sep/2024 | |
| 311 | Rosuvastatin 5 mg and Fenofibrate 67mg Tablets | 17/Sep/2024 | |
| 312 | Rosuvastatin 5mg and Fenofibrate 145mg Tablet | 17/Sep/2024 | |
| 313 | Rosuvastatin 5mg and Fenofibrate 160mg tablets | 17/Sep/2024 | |
| 314 | Rosuvastatin 10mg and Fenofibrate 67.5 mg Tablet | 17/Sep/2024 | |
| 315 | Rosuvastatin 10 mg and Fenofibrate 145 mg Tablets | 17/Sep/2024 | |
| 316 | Rosuvastatin 10mg and Fenofibrate 160mg tablets | 17/Sep/2024 | |
| 317 | Rosuvastatin 20mg and Fenofibrate 67.5mg Tablets | 17/Sep/2024 | |
| 318 | Rosuvastatin 20mg and Fenofibrate 145mg Tablets | 17/Sep/2024 | |
| 319 | Rosuvastatin 20 mg and Fenofibrate 160 mg tablets | 17/Sep/2024 | |
| 320 | Guanfacine hydrochloride ER Tablets 1 mg, 2 mg, 3 mg and 4 mg | 6/Dec/2024 | |
| 321 | Solifenacin Succinate 6mg and Tamsulosin Hydrochloride 0.4mg Modified Release Tablets | 6/Dec/2024 | |
| 322 | Sirolimus tablets 2 mg | 01.12.2003 | 6/Dec/2024 |
| 323 | Sirolimus tablets 1 mg | 6/Dec/2024 | |
| 324 | Sirolimus tablets 0.5 mg | 6/Dec/2024 | |
| 325 | MSP008-22 tablets 100 mg | 3/Jan/2025 | |
| 326 | MSP008-22 tablets 200 mg | 3/Jan/2025 | |
| 327 | MSP008-22 tablets 400 mg | 3/Jan/2025 | |
| 328 | MSP008-22 tablets 500 mg | 3/Jan/2025 | |
| 329 | MSP008-22 tablets 600 mg | 3/Jan/2025 | |
| 330 | MSP008-22 tablets 750 mg | 3/Jan/2025 | |
| 331 | Ritonavir capsules 100 mg | 3/Jan/2025 | |
| 332 | Ritonavir tablets 100 mg | 3/Jan/2025 | |
| 333 | Bosutinib film coated tablets 400 mg | Unapproved | Unapproved |
| 334 | Brivaracetam tablets 100 mg | Approved | 14/Aug/2025 |
| 335 | Pentoxifylline ER Tablets USP 400 mg | 19/Sep/2025 | |
| 336 | |||
| 337 | Sitagliptin Tablets USP 100 mg | Approved | 18/Nov/2025 |
| 338 | Sitagliptin Tablets USP 25 mg | Approved | 18/Nov/2025 |
| 339 | Sitagliptin Tablets USP 50 mg | Approved | 18/Nov/2025 |
| 340 | Dapagliflozin and Metformin HCl Extended release tablets 10/ 1000 mg | Unapproved | 6/Dec/2025 |
| 341 | Ursodeoxycholic acid Capsules USP 250 mg | Unapproved | 15/Feb/2026 |
| 342 | Ibuprofen tablets BP 400 mg | Approved | 8/Mar/2026 |
| 343 | Naproxen and Esomeprazole Magnesium Delayed Release Tablets 500/20mg | Unapproved | 8/Mar/2026 |
| 344 | Paracetamol tablets BP 500 mg | Approved | 8/Mar/2026 |
Indivar Sciences © All Right Reserved
